Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-10 Option Award |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
525 | $0 | 31,029 (Direct) |
View |
| 2025-04-10 Tax Withholding |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
176 | $6.91 | 31,029 (Direct) |
View |
| 2025-03-24 Tax Withholding |
2025-03-26 4:36 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
79 | $8.21 | 30,680 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-25 4:54 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
2,502 | $7.49 | 30,759 (Direct) |
View |
| 2025-02-13 Tax Withholding |
2025-02-14 4:26 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
627 | $7.18 | 33,261 (Direct) |
View |
| 2025-01-16 Option Award |
2025-01-21 4:12 pm |
N/A 2035-01-16 |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
42,000 | $0 | 61,888 (Direct) |
View |
| 2024-12-24 Tax Withholding |
2024-12-27 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
79 | $5.48 | 19,888 (Direct) |
View |
| 2024-11-01 Option Award |
2024-11-01 4:24 pm |
N/A 2034-10-31 |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
15,000 | $0 | 29,967 (Direct) |
View |
Ownership |
2024-11-01 4:23 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Shiferman Gregory L. See Remarks |
0 | $0 | 41,575 (Direct) |
View |